公司資料
Ironwood Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- IRWD
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
4.36 USD (+1.16%)
收盤價
最後更新: 2026年8月17日
540M USD
市值
股價為何變動
As of Aug 17, 2026, IRWD closed up 1.16% at $4.36. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Ironwood Pharmaceuticals is a gastrointestinal-focused company anchored by Linzess and a pipeline aimed at digestive health. Its story is centered on GI commercialization and pipeline extension.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Ironwood sits in specialty biopharma.
商業模式特徵
The business combines commercial GI revenue with pipeline optionality, so investors track prescription trends, partnership economics, and product durability.
生技產業定位
Ironwood is a commercial specialty-pharma name whose valuation is tied to a limited number of digestive-health assets and their lifecycle.
未來催化劑
- Ironwood's catalysts are Linzess execution, GI commercial stability, and any pipeline or partnership update that clarifies the next growth vector. The company still needs the core franchise to stay durable.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。